http://www.washingtonwatch.com/bills info@washingtonwatch.com http://www.pjdoland.com/chai/?v=0.1 http://www.washingtonwatch.com/bills/history/110_HR_3025.html?rev=9651 <p>H.R. 3025 would amend title XVIII of the Social Security Act to provide comprehensive improvements to the Medicare Prescription Drug Program.</p> <h2 id="toc0"> Detailed Summary </h2> <p>Medicare Prescription Drug Savings for Our Seniors (Medicare Prescription Drug SOS) Act of 2007 - Amends part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act (SSA) to direct the Secretary of Health and Human Services to: (1) offer one or more Medicare operated prescription drug plans (PDPs) with a service area consisting of the entire United States; and (2) negotiate with pharmaceutical manufacturers to reduce the purchase cost of covered part D drugs. Requires the monthly beneficiary premium for qualified prescription drug coverage and access to negotiated prices to be uniform nationally.</p> <p>Provides for auto-enrollment of subsidy eligible individuals in Medicare operated PDPs.</p> <p>Amends SSA title XIX (Medicaid) to provide for the use of 2005 as base in computing the state clawback provision.</p> <p>Amends SSA title XVIII (Medicare) to eliminate part D cost-sharing for certain non-institutionalized full-benefit dual eligible individuals.</p> <p>Provides for: (1) expedited low-income subsidies under the Medicare PDP; (2) indexing of deductible and cost-sharing for certain individuals; and (3) Commissioner of Social Security screening for Medicare savings program eligibility.</p> <p>Sets forth anti-fraud and abuse provisions.</p> <p>Provides for protection against a decrease in Social Security benefits owing to part D Medicare premium increases.</p> <p>Prohibits late enrollment penalties for months before January 2008. Allows a one-time change in plan during first year of enrollment.</p> <p>Prohibits a PDP sponsor from removing a covered part D drug from the plan formulary, downgrading its cost-sharing status, or otherwise introducing a barrier to access to covered part D drugs, without advance notice.</p> <p>Requires Medicare part D formularies to cover all drugs in six specified therapeutic categories.</p> <p>Makes benzodiazepines covered part D brugs, subject to review by the Secretary.</p> <p>Eliminates the MA Regional Stabilization Fund and certain Medicare Advantage overpayments.</p> <p>Requires prompt payment of clean claims by Medicare and Medicare Advantage PDPs.</p> <p>Prohibits co-branding.</p> <p>Extends part D coverage to medication therapy management services.</p> <!--Leave in the 'summary' tags if you want the latest summary from the Congressional Research Service automatically to replace the text between the tags once it becomes available. --> <h2 id="toc1"> Status of the Legislation </h2> <p>Latest Major Action: 7/12/2007: Referred to House committee. Status: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</p> <!-- Leave in the 'status' tags if you want the latest reported status from THOMAS automatically to replace the text between the tags once it becomes available. --> <h2 id="toc2"> Points in Favor </h2> <p>(Log in to edit the wiki and be the first to show why the bill should pass!)<br /> <!-- First editor: Go ahead and take out the sentence in parentheses, and this notice! --> </p> <h2 id="toc3"> Points Against </h2> <p>(Log in to edit the wiki and be the first to show why the bill should not pass!)<br /> <!-- First editor: Go ahead and take out the sentence in parentheses, and this notice! --> </p> 9651@http://www.washingtonwatch.com Tue, 11 Sep 2007 00:00:00 EDT http://www.washingtonwatch.com/bills/history/110_HR_3025.html?rev=4315 <p>H.R. 3025 would amend title XVIII of the Social Security Act to provide comprehensive improvements to the Medicare Prescription Drug Program.</p> <h2 id="toc4"> Detailed Summary </h2> <p>(Log in to edit the wiki and be the first to provide a detailed summary of the bill!)</p> <!--Leave in the 'summary' tags if you want the latest summary from the Congressional Research Service automatically to replace the text between the tags once it becomes available. --> <h2 id="toc5"> Status of the Legislation </h2> <p>(Log in to edit the wiki and be the first to update the status of the bill!)</p> <!-- Leave in the 'status' tags if you want the latest reported status from THOMAS automatically to replace the text between the tags once it becomes available. --> <h2 id="toc6"> Points in Favor </h2> <p>(Log in to edit the wiki and be the first to show why the bill should pass!)<br /> <!-- First editor: Go ahead and take out the sentence in parentheses, and this notice! --> </p> <h2 id="toc7"> Points Against </h2> <p>(Log in to edit the wiki and be the first to show why the bill should not pass!)<br /> <!-- First editor: Go ahead and take out the sentence in parentheses, and this notice! --> </p> 4315@http://www.washingtonwatch.com Fri, 13 Jul 2007 00:00:00 EDT http://www.washingtonwatch.com/bills/history/110_HR_3025.html?rev=4316 <p>H.R. 3025 would amend title XVIII of the Social Security Act to provide comprehensive improvements to the Medicare Prescription Drug Program.</p> <h2 id="toc8"> Detailed Summary </h2> <p>(Log in to edit the wiki and be the first to provide a detailed summary of the bill!)</p> <!--Leave in the 'summary' tags if you want the latest summary from the Congressional Research Service automatically to replace the text between the tags once it becomes available. --> <h2 id="toc9"> Status of the Legislation </h2> <p>Latest Major Action: 7/12/2007: Referred to House committee. Status: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</p> <!-- Leave in the 'status' tags if you want the latest reported status from THOMAS automatically to replace the text between the tags once it becomes available. --> <h2 id="toc10"> Points in Favor </h2> <p>(Log in to edit the wiki and be the first to show why the bill should pass!)<br /> <!-- First editor: Go ahead and take out the sentence in parentheses, and this notice! --> </p> <h2 id="toc11"> Points Against </h2> <p>(Log in to edit the wiki and be the first to show why the bill should not pass!)<br /> <!-- First editor: Go ahead and take out the sentence in parentheses, and this notice! --> </p> 4316@http://www.washingtonwatch.com Fri, 13 Jul 2007 00:00:00 EDT http://www.washingtonwatch.com/bills/show/110_HR_3025.html 7/12/2007: Referred to House committee. Status: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. 23553@http://www.washingtonwatch.com Thu, 12 Jul 2007 00:00:00 EDT http://www.washingtonwatch.com/bills/show/110_HR_3025.html 7/12/2007: Referred to House committee. Status: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. 28769@http://www.washingtonwatch.com Thu, 12 Jul 2007 00:00:00 EDT